comparemela.com
Home
Live Updates
AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants : comparemela.com
AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants
Cambridge: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of lower respiratory tract disease (LRTD) caused by...
Related Keywords
Nagasaki ,
Yamagata ,
Japan ,
China ,
Japanese ,
Hiroyuki Moriuchi ,
Iskra Reic ,
Astrazeneca ,
European Union ,
Japanese Ministry Of Health ,
Nagasaki University Graduate School Of Biomedical Sciences ,
Head Of Department Pediatrics ,
Japanese Ministry ,
Nagasaki University Graduate School ,
Biomedical Sciences ,
Executive Vice President ,
Immune Therapies ,
Astrazeneca News ,
Sanofi ,
Sanofi News ,
Beyfortus ,
Nirsevimab ,
Respiratory Syncytial Virus ,
Dr Hiroyuki Moriuchi ,
comparemela.com © 2020. All Rights Reserved.